Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease

Paschalis Steiropoulos, Nikolaos Papanas, Evangelia Nena, Demosthenes Bouros
  • Expert Opinion on Pharmacotherapy, April 2012, Informa Healthcare
  • DOI: 10.1517/14656566.2012.674513

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/14656566.2012.674513

The following have contributed to this page: Assistant Professor Paschalis Steiropoulos